Guoqing Chen
Amministratore Delegato presso Advenchen Laboratories LLC
Profilo
Guoqing Chen is the founder of Igenica Biotherapeutics, Inc. founded in 2008.
He is currently the Chief Executive Officer at Advenchen Laboratories LLC.
Dr. Chen's former positions include Director at Elevar Therapeutics, Inc., Senior Scientist at Amgen, Inc., and Scientist at Tularik, Inc. He holds a doctorate degree from the University of California, Los Angeles.
Posizioni attive di Guoqing Chen
Società | Posizione | Inizio |
---|---|---|
Advenchen Laboratories LLC
Advenchen Laboratories LLC Medical SpecialtiesHealth Technology Advenchen Laboratories LLC operates as a pharmaceutical company. It focuses on pharmaceutical research and development involving small molecule cancer drug discovery programs. The firm’s proprietary drug development product pipeline has demonstrated anti-tumor activities and therapeutic benefits. The company is headquartered in Moorpark, CA. | Amministratore Delegato | - |
Precedenti posizioni note di Guoqing Chen
Società | Posizione | Fine |
---|---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Direttore/Membro del Consiglio | - |
AMGEN INC. | Corporate Officer/Principal | - |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Fondatore | - |
Formazione di Guoqing Chen
University of California, Los Angeles | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
AMGEN INC. | Health Technology |
Aziende private | 4 |
---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Health Technology |
Advenchen Laboratories LLC
Advenchen Laboratories LLC Medical SpecialtiesHealth Technology Advenchen Laboratories LLC operates as a pharmaceutical company. It focuses on pharmaceutical research and development involving small molecule cancer drug discovery programs. The firm’s proprietary drug development product pipeline has demonstrated anti-tumor activities and therapeutic benefits. The company is headquartered in Moorpark, CA. | Health Technology |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
- Borsa valori
- Insiders
- Guoqing Chen